Insulet Corp. Sets New 1-Year High at $40.92 (PODD)
Insulet Corp. (NASDAQ:PODD) set a new 52-week high during trading hours on Friday, Stock Ratings Network.com reports. The company traded as high as $40.92 and last traded at $40.06, with a volume of 1,249,441 shares. The stock had previously closed at $40.31.
PODD has been the subject of a number of recent research reports. Analysts at Zacks downgraded shares of Insulet Corp. from a “neutral” rating to an “underperform” rating in a research note to investors on Monday. They now have a $34.40 price target on the stock. Separately, analysts at CRT Capital initiated coverage on shares of Insulet Corp. in a research note to investors on Monday, January 6th. They set a “buy” rating and a $53.00 price target on the stock. Finally, analysts at Raymond James upgraded shares of Insulet Corp. from a “market perform” rating to an “outperform” rating in a research note to investors on Friday, November 22nd. They now have a $43.00 price target on the stock. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have issued a buy rating to the stock. Insulet Corp. has an average rating of “Hold” and an average price target of $36.53.
In other Insulet Corp. news, COO Charles Liamos sold 86,000 shares of the company’s stock in a transaction dated Friday, January 3rd. The shares were sold at an average price of $36.02, for a total transaction of $3,097,720.00. Following the completion of the sale, the chief operating officer now directly owns 77,316 shares in the company, valued at approximately $2,784,922. The sale was disclosed in a document filed with the SEC, which is available at this link.
Insulet Corp. (NASDAQ:PODD) last announced its earnings results on Thursday, November 7th. The company reported ($0.39) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by $0.23. The company had revenue of $61.10 million for the quarter, compared to the consensus estimate of $62.01 million. During the same quarter in the previous year, the company posted ($0.26) earnings per share. The company’s revenue for the quarter was up 11.5% on a year-over-year basis.
Insulet Corporation is primarily engaged in the development, manufacturing and sale of its OmniPod Insulin Management System (NASDAQ:PODD).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.